NEW YORK (GenomeWeb News) - Ariadne said today it has recently licensed its Pathway Studio Enterprise software to five Japanese pharmaceutical companies through its distribution partner World Fusion.
The software is used to analyze data from microarray, proteomics, and other experiments and is supported by the company’s Resnet mammalian and plant databases.
Ariadne said World Fusion has been distributing its products in Japan since 2004.
Ariadne did not name the five pharmaceutical companies that have licensed its software.
Financial terms of the agreements were not released.